Exoskeleton Market
Description
Size, Share, And Trend Analysis Report, By Mobility (Mobile, Fixed/Stationary), By Technology (Powered, Non-powered), By Extremity (Upper Body, Lower Body), By End Use (Healthcare, Military), By Region, And Segment Forecasts, 2026 - 2033
Exoskeleton Market Summary
The global exoskeleton market size was estimated at USD 590.02 million in 2025 and is projected to reach USD 1.79 billion by 2033, growing at a CAGR of 14.48% from 2026 to 2033. Rapidly growing global geriatric population, rising adoption rates of medical devices in different industries such as automobile, military, defense, and construction, and rising incidence of stroke are some of the key driving forces responsible for the exoskeleton market growth.
Furthermore, the growing incidence rate of spinal cord injuries (SCI) is expected to drive the demand across global markets. For instance, as per the National Spinal Cord Injury Statistical Center (NSCISC), in the U.S., 17,730 new SCIs are diagnosed annually, and approximately 291,000 live with SCIs.
Exoskeleton solutions are widely adopted across industries to support employee health and boost productivity, positioning them as a critical segment within the broader wearable robot market. Growing demand has led to emergence of several startups expertizing in exoskeleton technology and providing solutions for rehabilitation. Furthermore, constantly evolving exoskeleton industry is driving market players to devise innovative product development strategies to boost adoption over the forecast period. In January 2026, RoboCT introduced its lightweight GoGo Exoskeleton series at CES 2026, marking the company’s expansion from clinical rehabilitation into consumer-focused daily mobility solutions. The 2.3 kg AI-powered wearable offers multi-mode, real-time adaptive support for activities such as walking, sitting, and balance assistance, targeting post-stroke recovery, neurodegenerative conditions, and everyday mobility needs.
Increasing prevalence of spinal cord injury is boosting the growth of the exoskeleton segment within the wearable robot market, as patients are increasingly recommended to use robotic wearable assistive devices to improve mobility and functional outcomes. RaThis has become major driver for adoption of exoskeleton by patients as well as healthcare providers. In September 2025, United Spinal Association reported that 250,000 to 390,000 people in the U.S. are living with spinal cord injury, with about 18,000 new cases each year, most often due to vehicle accidents and falls, and highlighted common secondary complications including depression, chronic pain, spasticity, pressure injuries, and bowel, bladder, and respiratory issues.
Some of the most common musculoskeletal injuries and disorders affecting the construction industry are occupational overuse syndrome (OOS), cumulative trauma disorders (CTD), and repetitive strain injury (RSI). For instance, as per WHO data estimates published in July 2022, approximately 1.71 billion individuals across the globe have musculoskeletal disorders that include neck pain, lower back pain, fractures, amputation, rheumatoid arthritis, and osteoarthritis. Similarly, in 2022, according to the U.S. Bureau of Labor Statistics, approximately 502,380 workers have occupation-related musculoskeletal disorders across several industries. These are some of the driving factors boosting adoption of exoskeleton solutions owing to benefits associated with exoskeleton technology, such as augmenting or assisting users’ physical activity or capability, improving users’ health & productivity, and reducing fatigue experienced by industrial workers.
Rapid technological advancements in the exoskeleton segment of the wearable robot market are expected to boost demand for robotic assistive devices across healthcare and industrial applications. Increasing popularity and growing adoption of exoskeletons by companies are expected to contribute to market growth. In addition, increasing adoption of exoskeletons in manufacturing sector, logistics, automotive, and construction is leading to a rise in penetration of exoskeletons, thereby fueling the market growth. In May 2025, Wandercraft initiated clinical trials of its AI powered Personal Exoskeleton, using NVIDIA AI and simulation tools to enable individuals with spinal cord injuries, stroke, and severe mobility impairments to stand and walk with real time adaptive support.
The trend of including exoskeletons in health insurance coverage is rising, making them more accessible to patients. This is particularly evident in countries such as Germany, where specific exoskeleton systems are recognized for insurance procurement. For instance, in November 2023, ReWalk Robotics Ltd. appreciated the Centers for Medicare & Medicaid Services (CMS) for officially publishing the Calendar Year 2024 Home Health Prospective Payment System Rule. This regulation, which was issued on November 1, 2023, and is set to be implemented starting from January 1, 2024, confirms the classification of exoskeletons under the Medicare brace benefit category.
Global Exoskeleton Market Report Segmentation
This report forecasts revenue and volume growth at global, regional, and country level and provides an analysis on industry trends in each of the sub segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the exoskeleton market report on the basis of mobility, technology, extremity, end use and region:
Exoskeleton Market Summary
The global exoskeleton market size was estimated at USD 590.02 million in 2025 and is projected to reach USD 1.79 billion by 2033, growing at a CAGR of 14.48% from 2026 to 2033. Rapidly growing global geriatric population, rising adoption rates of medical devices in different industries such as automobile, military, defense, and construction, and rising incidence of stroke are some of the key driving forces responsible for the exoskeleton market growth.
Furthermore, the growing incidence rate of spinal cord injuries (SCI) is expected to drive the demand across global markets. For instance, as per the National Spinal Cord Injury Statistical Center (NSCISC), in the U.S., 17,730 new SCIs are diagnosed annually, and approximately 291,000 live with SCIs.
Exoskeleton solutions are widely adopted across industries to support employee health and boost productivity, positioning them as a critical segment within the broader wearable robot market. Growing demand has led to emergence of several startups expertizing in exoskeleton technology and providing solutions for rehabilitation. Furthermore, constantly evolving exoskeleton industry is driving market players to devise innovative product development strategies to boost adoption over the forecast period. In January 2026, RoboCT introduced its lightweight GoGo Exoskeleton series at CES 2026, marking the company’s expansion from clinical rehabilitation into consumer-focused daily mobility solutions. The 2.3 kg AI-powered wearable offers multi-mode, real-time adaptive support for activities such as walking, sitting, and balance assistance, targeting post-stroke recovery, neurodegenerative conditions, and everyday mobility needs.
Increasing prevalence of spinal cord injury is boosting the growth of the exoskeleton segment within the wearable robot market, as patients are increasingly recommended to use robotic wearable assistive devices to improve mobility and functional outcomes. RaThis has become major driver for adoption of exoskeleton by patients as well as healthcare providers. In September 2025, United Spinal Association reported that 250,000 to 390,000 people in the U.S. are living with spinal cord injury, with about 18,000 new cases each year, most often due to vehicle accidents and falls, and highlighted common secondary complications including depression, chronic pain, spasticity, pressure injuries, and bowel, bladder, and respiratory issues.
Some of the most common musculoskeletal injuries and disorders affecting the construction industry are occupational overuse syndrome (OOS), cumulative trauma disorders (CTD), and repetitive strain injury (RSI). For instance, as per WHO data estimates published in July 2022, approximately 1.71 billion individuals across the globe have musculoskeletal disorders that include neck pain, lower back pain, fractures, amputation, rheumatoid arthritis, and osteoarthritis. Similarly, in 2022, according to the U.S. Bureau of Labor Statistics, approximately 502,380 workers have occupation-related musculoskeletal disorders across several industries. These are some of the driving factors boosting adoption of exoskeleton solutions owing to benefits associated with exoskeleton technology, such as augmenting or assisting users’ physical activity or capability, improving users’ health & productivity, and reducing fatigue experienced by industrial workers.
Rapid technological advancements in the exoskeleton segment of the wearable robot market are expected to boost demand for robotic assistive devices across healthcare and industrial applications. Increasing popularity and growing adoption of exoskeletons by companies are expected to contribute to market growth. In addition, increasing adoption of exoskeletons in manufacturing sector, logistics, automotive, and construction is leading to a rise in penetration of exoskeletons, thereby fueling the market growth. In May 2025, Wandercraft initiated clinical trials of its AI powered Personal Exoskeleton, using NVIDIA AI and simulation tools to enable individuals with spinal cord injuries, stroke, and severe mobility impairments to stand and walk with real time adaptive support.
The trend of including exoskeletons in health insurance coverage is rising, making them more accessible to patients. This is particularly evident in countries such as Germany, where specific exoskeleton systems are recognized for insurance procurement. For instance, in November 2023, ReWalk Robotics Ltd. appreciated the Centers for Medicare & Medicaid Services (CMS) for officially publishing the Calendar Year 2024 Home Health Prospective Payment System Rule. This regulation, which was issued on November 1, 2023, and is set to be implemented starting from January 1, 2024, confirms the classification of exoskeletons under the Medicare brace benefit category.
Global Exoskeleton Market Report Segmentation
This report forecasts revenue and volume growth at global, regional, and country level and provides an analysis on industry trends in each of the sub segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the exoskeleton market report on the basis of mobility, technology, extremity, end use and region:
- Mobility Outlook (Volume, 000' Units, Revenue USD Million 2021 - 2033)
- Mobile
- Fixed/Stationary
- Technology Outlook (Volume, 000' Units, Revenue USD Million 2021 - 2033)
- Powered
- Upper Body
- Lower Body
- Full Body
- Non-powered
- Upper Body
- Lower Body
- Full Body
- Extremity Outlook (Volume, 000' Units, Revenue USD Million 2021 - 2033)
- Upper Body
- Lower Body
- Full Body
- End Use Outlook (Volume, 000' Units, Revenue USD Million 2021 - 2033)
- Healthcare
- Military
- Industry
- Regional Outlook (Volume, 000' Units, Revenue USD Million 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- Spain
- Italy
- France
- Denmark
- Norway
- Sweden
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
150 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Mobility
- 1.2.2. Technology
- 1.2.3. Extremity
- 1.2.4. End Use
- 1.2.5. Regional scope
- 1.2.6. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR’s internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Mobility outlook
- 2.2.2. Technology outlook
- 2.2.3. Extremity outlook
- 2.2.4. End use outlook
- 2.2.5. Regional outlook
- 2.3. Competitive Insights
- Chapter 3. Exoskeleton Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing incidence of spinal cord injury
- 3.2.1.2. Increasing incidence of musculoskeletal disorders
- 3.2.1.3. Technological advancements
- 3.2.2. Market restraint analysis
- 3.2.2.1. High procedural costs
- 3.2.3. Market opportunity analysis
- 3.2.4. Market challenges analysis
- 3.3. Exoskeleton Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s Five Forces
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Environmental landscape
- 3.3.2.5. Legal Landscape
- 3.4. Key Trends in the Exoskeleton/Exo Robots Market
- 3.5. Key Developments in the Exoskeleton/Exo Robots Market
- 3.6. Patent Analysis
- 3.7. Patent Disputer
- 3.8. Case Studies & Insights
- 3.9. Supply Chain Analysis for Exoskeletons
- 3.10. Current Regulatory Analysis
- 3.11. Ecosystem Analysis
- 3.12. Pricing Analysis
- 3.13. Upcoming Innovations in the Market
- Chapter 4. Exoskeleton Market Segment Analysis, By Mobility 2021 - 2033 (USD Million), Unit Volume (In Thousand)
- 4.1. Definition and Scope
- 4.2. Mobility Market Share Analysis, 2025 & 2033
- 4.3. Segment Dashboard
- 4.4. Global Exoskeleton Market, By Mobility, 2021 - 2033
- 4.5. Exoskeleton Market Size & Forecasts, By Mobility, 2021 – 2033 (USD Million)
- 4.6. Exoskeleton Market Size & Forecasts, By Mobility, Unit Volume, 2021 – 2033 (In Thousand Units)
- 4.7. Mobile
- 4.7.1. Mobile market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
- 4.8. Fixed/Stationary
- 4.8.1. Fixed/stationary market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
- Chapter 5. Exoskeleton Market Segment Analysis, By Technology 2021 - 2033 (USD Million), Unit Volume (In Thousand)
- 5.1. Definition and Scope
- 5.2. Technology Market Share Analysis, 2025 & 2033
- 5.3. Segment Dashboard
- 5.4. Global Exoskeleton Market, By Technology, 2021 - 2033
- 5.5. Exoskeleton Market Size & Forecasts, By Technology, 2021 – 2033 (USD Million)
- 5.6. Exoskeleton Market Size & Forecasts, By Technology, Unit Volume, 2021 – 2033 (In Thousand Units)
- 5.7. Powered
- 5.7.1. Powered market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
- 5.7.2. Powered by Extremity
- 5.7.2.1. Upper body
- 5.7.2.1.1. Upper body market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
- 5.7.2.2. Lower body
- 5.7.2.2.1. Lower body market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
- 5.7.2.3. Full body
- 5.7.2.3.1. Full body market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
- 5.8. Non-Powered
- 5.8.1. Non-powered market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
- 5.8.2. Non-powered by Extremity
- 5.8.2.1. Upper body
- 5.8.2.1.1. Upper body market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
- 5.8.2.2. Lower body
- 5.8.2.2.1. Lower body market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
- 5.8.2.3. Full body
- 5.8.2.3.1. Full body market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
- Chapter 6. Exoskeleton Market Segment Analysis, By Extremity 2021 - 2033 (USD Million), Unit Volume (In Thousand)
- 6.1. Definition and Scope
- 6.2. Extremity Market Share Analysis, 2025 & 2033
- 6.3. Segment Dashboard
- 6.4. Global Exoskeleton Market, By Extremity, 2021 - 2033
- 6.5. Exoskeleton Market Size & Forecasts, By Extremity, 2021 – 2033 (USD Million)
- 6.6. Exoskeleton Market Size & Forecasts, By Extremity, Unit Volume, 2021 – 2033 (In Thousand Units)
- 6.7. Upper Body
- 6.7.1. Upper body market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
- 6.8. Lower Body
- 6.8.1. Lower body market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
- 6.9. Full Body
- 6.9.1. Full body market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
- Chapter 7. Exoskeleton Market: End Use Estimates & Trend Analysis
- 7.1. Definition and Scope
- 7.2. End Use Market Share Analysis, 2025 & 2033
- 7.3. Segment Dashboard
- 7.4. Global Exoskeleton Market, By End Use, 2021 - 2033
- 7.5. Exoskeleton Market Size & Forecasts, By End Use, 2021 – 2033 (USD Million)
- 7.6. Exoskeleton Market Size & Forecasts, By End Use, Unit Volume, 2021 – 2033 (In Thousand Units)
- 7.7. Healthcare
- 7.7.1. Healthcare market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
- 7.8. Military
- 7.8.1. Military market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
- 7.9. Industry
- 7.9.1. Industry market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
- Chapter 8. Exoskeleton Market: Regional Estimates & Trend Analysis by mobility, technology, extremity, and end use
- 8.1. Regional Market Share Analysis, 2025 & 2033
- 8.2. Regional Dashboard
- 8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
- 8.4. North America
- 8.4.1. U.S.
- 8.4.1.1. Key country dynamics
- 8.4.1.2. Regulatory framework
- 8.4.1.3. Competitive scenario
- 8.4.1.4. Market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.1.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
- 8.4.2. Canada
- 8.4.2.1. Key country dynamics
- 8.4.2.2. Regulatory framework
- 8.4.2.3. Competitive scenario
- 8.4.2.4. Market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.2.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
- 8.4.3. Mexico
- 8.4.3.1. Key country dynamics
- 8.4.3.2. Regulatory framework
- 8.4.3.3. Competitive scenario
- 8.4.3.4. Market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.3.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
- 8.5. Europe
- 8.5.1. UK
- 8.5.1.1. Key country dynamics
- 8.5.1.2. Regulatory framework
- 8.5.1.3. Competitive scenario
- 8.5.1.4. Market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.1.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
- 8.5.2. Germany
- 8.5.2.1. Key country dynamics
- 8.5.2.2. Regulatory framework
- 8.5.2.3. Competitive scenario
- 8.5.2.4. Market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.2.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
- 8.5.3. France
- 8.5.3.1. Key country dynamics
- 8.5.3.2. Regulatory framework
- 8.5.3.3. Competitive scenario
- 8.5.3.4. Market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.3.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
- 8.5.4. Italy
- 8.5.4.1. Key country dynamics
- 8.5.4.2. Regulatory framework
- 8.5.4.3. Competitive scenario
- 8.5.4.4. Market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.4.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
- 8.5.5. Spain
- 8.5.5.1. Key country dynamics
- 8.5.5.2. Regulatory framework
- 8.5.5.3. Competitive scenario
- 8.5.5.4. Market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.5.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
- 8.5.6. Denmark
- 8.5.6.1. Key country dynamics
- 8.5.6.2. Regulatory framework
- 8.5.6.3. Competitive scenario
- 8.5.6.4. Market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.6.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
- 8.5.7. Sweden
- 8.5.7.1. Key country dynamics
- 8.5.7.2. Regulatory framework
- 8.5.7.3. Competitive scenario
- 8.5.7.4. Market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.7.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
- 8.5.8. Norway
- 8.5.8.1. Key country dynamics
- 8.5.8.2. Regulatory framework
- 8.5.8.3. Competitive scenario
- 8.5.8.4. Market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.8.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
- 8.6. Asia Pacific
- 8.6.1. Japan
- 8.6.1.1. Key country dynamics
- 8.6.1.2. Regulatory framework
- 8.6.1.3. Competitive scenario
- 8.6.1.4. Market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.1.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
- 8.6.2. China
- 8.6.2.1. Key country dynamics
- 8.6.2.2. Regulatory framework
- 8.6.2.3. Competitive scenario
- 8.6.2.4. Market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.2.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
- 8.6.3. India
- 8.6.3.1. Key country dynamics
- 8.6.3.2. Regulatory framework
- 8.6.3.3. Competitive scenario
- 8.6.3.4. Market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.3.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
- 8.6.4. South Korea
- 8.6.4.1. Key country dynamics
- 8.6.4.2. Regulatory framework
- 8.6.4.3. Competitive scenario
- 8.6.4.4. Market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.4.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
- 8.6.5. Thailand
- 8.6.5.1. Key country dynamics
- 8.6.5.2. Regulatory framework
- 8.6.5.3. Competitive scenario
- 8.6.5.4. Market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.5.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
- 8.6.6. Australia
- 8.6.6.1. Key country dynamics
- 8.6.6.2. Regulatory framework
- 8.6.6.3. Competitive scenario
- 8.6.6.4. Market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.6.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
- 8.7. Latin America
- 8.7.1. Brazil
- 8.7.1.1. Key country dynamics
- 8.7.1.2. Regulatory framework
- 8.7.1.3. Competitive scenario
- 8.7.1.4. Market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.1.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
- 8.7.2. Argentina
- 8.7.2.1. Key country dynamics
- 8.7.2.2. Regulatory framework
- 8.7.2.3. Competitive scenario
- 8.7.2.4. Market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.2.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
- 8.8. MEA
- 8.8.1. South Africa
- 8.8.1.1. Key country dynamics
- 8.8.1.2. Regulatory framework
- 8.8.1.3. Competitive scenario
- 8.8.1.4. Market estimates and forecasts 2021 to 2033 (USD Million)
- 8.8.1.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
- 8.8.2. Saudi Arabia
- 8.8.2.1. Key country dynamics
- 8.8.2.2. Regulatory framework
- 8.8.2.3. Competitive scenario
- 8.8.2.4. Market estimates and forecasts 2021 to 2033 (USD Million)
- 8.8.2.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
- 8.8.3. UAE
- 8.8.3.1. Key country dynamics
- 8.8.3.2. Regulatory framework
- 8.8.3.3. Competitive scenario
- 8.8.3.4. Market estimates and forecasts 2021 to 2033 (USD Million)
- 8.8.3.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
- 8.8.4. Kuwait
- 8.8.4.1. Key country dynamics
- 8.8.4.2. Regulatory framework
- 8.8.4.3. Competitive scenario
- 8.8.4.4. Market estimates and forecasts 2021 to 2033 (USD Million)
- 8.8.4.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
- Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Company/Competition Categorization
- 9.3. Exoskeleton/Exo Robots Key Market Performance Indicators
- 9.4. Company Profiles
- 9.4.1. Ekso Bionics
- 9.4.1.1. Overview
- 9.4.1.2. Financial performance
- 9.4.1.3. Product benchmarking
- 9.4.1.4. Strategic initiatives
- 9.4.2. ARMASTEC PTE. LTD.
- 9.4.2.1. Overview
- 9.4.2.2. Financial performance
- 9.4.2.3. Product benchmarking
- 9.4.2.4. Strategic initiatives
- 9.4.3. Hocoma
- 9.4.3.1. Overview
- 9.4.3.2. Financial performance
- 9.4.3.3. Product benchmarking
- 9.4.3.4. Strategic initiatives
- 9.4.4. Lockheed Martin Corporation
- 9.4.4.1. Overview
- 9.4.4.2. Financial performance
- 9.4.4.3. Product benchmarking
- 9.4.4.4. Strategic initiatives
- 9.4.5. Suit X
- 9.4.5.1. Overview
- 9.4.5.2. Financial performance
- 9.4.5.3. Product benchmarking
- 9.4.5.4. Strategic initiatives
- 9.4.6. Rex Bionics Plc.
- 9.4.6.1. Overview
- 9.4.6.2. Financial performance
- 9.4.6.3. Product benchmarking
- 9.4.6.4. Strategic initiatives
- 9.4.7. RB3D
- 9.4.7.1. Overview
- 9.4.7.2. Financial performance
- 9.4.7.3. Product benchmarking
- 9.4.7.4. Strategic initiatives
- 9.4.8. ReWalk Robotics
- 9.4.8.1. Overview
- 9.4.8.2. Financial performance
- 9.4.8.3. Product benchmarking
- 9.4.8.4. Strategic initiatives
- 9.4.9. Cyberdyne, Inc.
- 9.4.9.1. Overview
- 9.4.9.2. Financial performance
- 9.4.9.3. Product benchmarking
- 9.4.9.4. Strategic initiatives
- 9.4.10. ActiveLink (Panasonic Corporation)
- 9.4.10.1. Overview
- 9.4.10.2. Financial performance
- 9.4.10.3. Product benchmarking
- 9.4.10.4. Strategic initiatives
- 9.4.11. DIH Medical
- 9.4.11.1. Overview
- 9.4.11.2. Financial performance
- 9.4.11.3. Product benchmarking
- 9.4.11.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


